_version_ 1784611892442955776
author Konishi, Yoshinobu
Sklavenitis-Pistofidis, Romanos
Yue, Hong
Ferrari, Federico
Redd, Robert A.
Lightbody, Elizabeth D.
Russo, Massimiliano
Perry, Jacqueline
Horowitz, Erica
Justis, Anna V.
Shayegh, Nader A.
Savell, Alexandra
Prescott, Julia
Varmeh, Shohreh
Nowak, Radosław P.
Hamilton, Mark
Auclair, Daniel
Marinac, Catherine R.
Trippa, Lorenzo
Fischer, Eric S.
Ghobrial, Irene M.
author_facet Konishi, Yoshinobu
Sklavenitis-Pistofidis, Romanos
Yue, Hong
Ferrari, Federico
Redd, Robert A.
Lightbody, Elizabeth D.
Russo, Massimiliano
Perry, Jacqueline
Horowitz, Erica
Justis, Anna V.
Shayegh, Nader A.
Savell, Alexandra
Prescott, Julia
Varmeh, Shohreh
Nowak, Radosław P.
Hamilton, Mark
Auclair, Daniel
Marinac, Catherine R.
Trippa, Lorenzo
Fischer, Eric S.
Ghobrial, Irene M.
author_sort Konishi, Yoshinobu
collection PubMed
description
format Online
Article
Text
id pubmed-8654583
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-86545832021-12-09 Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia Konishi, Yoshinobu Sklavenitis-Pistofidis, Romanos Yue, Hong Ferrari, Federico Redd, Robert A. Lightbody, Elizabeth D. Russo, Massimiliano Perry, Jacqueline Horowitz, Erica Justis, Anna V. Shayegh, Nader A. Savell, Alexandra Prescott, Julia Varmeh, Shohreh Nowak, Radosław P. Hamilton, Mark Auclair, Daniel Marinac, Catherine R. Trippa, Lorenzo Fischer, Eric S. Ghobrial, Irene M. Cancer Cell Letter Elsevier Inc. 2022-01-10 2021-12-09 /pmc/articles/PMC8654583/ /pubmed/34895486 http://dx.doi.org/10.1016/j.ccell.2021.12.003 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter
Konishi, Yoshinobu
Sklavenitis-Pistofidis, Romanos
Yue, Hong
Ferrari, Federico
Redd, Robert A.
Lightbody, Elizabeth D.
Russo, Massimiliano
Perry, Jacqueline
Horowitz, Erica
Justis, Anna V.
Shayegh, Nader A.
Savell, Alexandra
Prescott, Julia
Varmeh, Shohreh
Nowak, Radosław P.
Hamilton, Mark
Auclair, Daniel
Marinac, Catherine R.
Trippa, Lorenzo
Fischer, Eric S.
Ghobrial, Irene M.
Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
title Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
title_full Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
title_fullStr Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
title_full_unstemmed Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
title_short Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
title_sort attenuated response to sars-cov-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and waldenstrom macroglobulinemia
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654583/
https://www.ncbi.nlm.nih.gov/pubmed/34895486
http://dx.doi.org/10.1016/j.ccell.2021.12.003
work_keys_str_mv AT konishiyoshinobu attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT sklavenitispistofidisromanos attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT yuehong attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT ferrarifederico attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT reddroberta attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT lightbodyelizabethd attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT russomassimiliano attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT perryjacqueline attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT horowitzerica attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT justisannav attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT shayeghnadera attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT savellalexandra attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT prescottjulia attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT varmehshohreh attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT nowakradosławp attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT hamiltonmark attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT auclairdaniel attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT marinaccatheriner attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT trippalorenzo attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT fischererics attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia
AT ghobrialirenem attenuatedresponsetosarscov2vaccineinpatientswithasymptomaticprecursorstagesofmultiplemyelomaandwaldenstrommacroglobulinemia